Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers [NA]

View source ↗

Summary

A clinical trial is currently recruiting to assess whether combining Akkermansia muciniphila and berberine improves insulin sensitivity in night-shift workers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Akkermansia muciniphila (Akkermansia muciniphila)
  • Berberine (berberine)

Snippet

Sponsor: FH Joanneum Gesellschaft mbH | Conditions: Obesity & Overweight, Circadian Rhythm Disorders | NA | Status: RECRUITING